DE PLACIDO, SABINO

DE PLACIDO, SABINO  

DIPARTIMENTO DI SANITA' PUBBLICA  

Mostra records
Risultati 1 - 20 di 492 (tempo di esecuzione: 0.024 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. 1.1 Articolo in rivista 2000 Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello,
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. 1.1 Articolo in rivista 1999 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; DE LORENZO, Sonya; Pepe, Stefano; DE PLACIDO, Sabino; Fan, Z; Mendelsohn, J; Bianco, A. R.; Tortora, Giampaolo
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. 1.1 Articolo in rivista 2000 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity 1.1 Articolo in rivista 2003 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; ZANGEMEISTER WITTKE, U; Ciardiello, F.
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. 1.1 Articolo in rivista 2004 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. 1.1 Articolo in rivista 2005 Damiano, V; Melisi, D; Bianco, C; Raben, D; Caputo, R; Fontanini, G; Bianco, Roberto; Ryan, A; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. 1.1 Articolo in rivista 2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. 1.1 Articolo in rivista 2000 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
ZD1839 (Iressa): preclinical studies and pharmacology 2.1 Contributo in volume (Capitolo o Saggio) 2002 Ciardiello, F; Tortora, G; DE PLACIDO, Sabino; Bianco, Ar
RESULTS OF ADJUVANT TREATMENT IN BREAST CANCER WOMEN AGED MORE THAN 70: ITALIAN COOPERATIVE GROUP EXPERIENCE. 2.1 Contributo in volume (Capitolo o Saggio) 2002 Mustacchi, G; Ceccherini, R; Pluchinotta, A; DE MATTEIS, Maria Antonietta; Maiorino, L; Farris, A; Scanni, A; DE PLACIDO, Sabino
Role of chemotherapy in hormone – refractory prostate cancer. Old issues, recent advances and new perspectives. 2.1 Contributo in volume (Capitolo o Saggio) 2003 Autorino, R; DI LORENZO, G; Damiano, R; DE PLACIDO, Sabino; Darmiento, M.
COMBINED TARGETING OF EGFR AND MDM2 BY GEFITINIB AND ANTISENSE MDM2 COOPERATIVELY INHIBIT HORMONE-INDEPENDENT PROSTATE CANCER. 1.1 Articolo in rivista 2004 Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; DE PLACIDO, Sabino; Ficorella, C; Agrawal, S; Bianco, Ar; Ciardiello, F; G., Tortora
[The request for consent in clinical research: a randomized study in healthy subjects] 1.1 Articolo in rivista 1995 F., Perrone; DE PLACIDO, Sabino; C., Giusti; C., Gallo
Lifetime total and beverage specific--alcohol intake and prostate cancer risk: a case-control study. 1.1 Articolo in rivista 2004 Maddalena, Barba; Susan E., Mccann; Holger J., Schünemann; Saverio, Stranges; Barbara, Fuhrman; DE PLACIDO, Sabino; Giuseppe, Carruba; Jo L., Freudenheim; Maurizio, Trevisan; Marcia, Russell; Tom, Nochajski; Paola, Muti
Insurance for independent cancer trials. 1.1 Articolo in rivista 2004 F., Perrone; M., Marangolo; F., Di Costanzo; G., Colucci; L., Repetto; M., Merlano; DE PLACIDO, Sabino; V., Torri; G., Comella; R., Labianca; V., Parisi; C., Gallo
Pegylated liposomal doxorubicin in stage IVB mycosis fungoides. 1.1 Articolo in rivista 2005 DI LORENZO, Giuseppe; R., Di Trolio; M., Delfino; DE PLACIDO, Sabino
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study. 1.1 Articolo in rivista 1990 DE PLACIDO, Sabino; C., Gallo; Marinelli, Alfredo; F., Perrone; Pagliarulo, Clorindo; Petrella, Giuseppe; Delrio, Giovanni; M., D'Istria; L., Del Mastro; Bianco, ANGELO RAFFAELE
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. 1.1 Articolo in rivista 1989 M., Lopez; Contegiacomo, Alma; P., Vici; C., Dello Ioio; L., Di Lauro; Pagliarulo, Clorindo; S., Carpano; D., Giannarelli; DE PLACIDO, Sabino; Fazio, Serafino
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients. 1.1 Articolo in rivista 1988 R. V., Iaffaioli; A., Bianchin; Ruggiero, Giuseppina; G., Pirozzi; A., Ungaro; G., Totaro; C., Gallo; DE PLACIDO, Sabino; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen. 1.1 Articolo in rivista 1986 Delrio, Giovanni; DE PLACIDO, Sabino; Pagliarulo, Clorindo; M., D'Istria; S., Fasano; Marinelli, Alfredo; F., Citarella; L., De Sio; Contegiacomo, Alma; R. V., Iaffaioli